http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014045902-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19b2f4e75db08ca968165636377fa5f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbd1d44888f5b41142d83de455096387 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fa747c3c5e4396cbb41536616516efc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_131d2c8a4e31bab5968628e4d231b2ea |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
| filingDate | 2012-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49eb4159f71f42f6889b62314300f048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_674a5a85a1f52f75110df0149189be05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21847c7a662aff08d66fb5422d23f116 |
| publicationDate | 2014-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2014045902-A1 |
| titleOfInvention | New triazole compounds as potential anti-inflammatory agents |
| abstract | The present invention relates to a compound of formula 1 or 2 n n n n n n n n n n wherein R 1 represents straight-chain or branched C 2 -C 8 alkyl, C 2 -C 8 alkenyl, optionally substituted by at least one substituent selected from the group consisting of hydroxyl, amino or C 1 -C 6 alkyl amino group, or C 2 -C 4 alkynyl, optionally substituted by at least one substituent selected from the group consisting of hydroxyl, amino or C 1 -C 6 alkyl amino group; and R 2 represents hydroxyl, C 1 -C 6 alkyl, C 1 -C 6 alkylcarbonyl, di(C 1 -C 6 -alkyl)aminomethyl, C 3 -C 6 heterocyclylmethyl or arylaminomethyl, wherein the aryl group is optionally substituted by at least one substituent selected from the group consisting of halogens and C 1 -C 6 alkoxy as well as associated pharmaceutical compositions and uses of the compound or composition in therapy, in particular for the treatment of a disorder or a disease susceptible to inhibition of COX-2. |
| priorityDate | 2011-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 222.